General Information of Drug Off-Target (DOT) (ID: OTW1V1L5)

DOT Name Protein BEX3 (BEX3)
Synonyms Brain-expressed X-linked protein 3; Nerve growth factor receptor-associated protein 1; Ovarian granulosa cell 13.0 kDa protein HGR74; p75NTR-associated cell death executor
Gene Name BEX3
Related Disease
Thyroid gland papillary carcinoma ( )
Advanced cancer ( )
Glaucoma/ocular hypertension ( )
Neoplasm ( )
Tuberous sclerosis ( )
Nasopharyngeal carcinoma ( )
Neuroblastoma ( )
UniProt ID
BEX3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF04538
Sequence
MANIHQENEEMEQPMQNGEEDRPLGGGEGHQPAGNRRGQARRLAPNFRWAIPNRQINDGM
GGDGDDMEIFMEEMREIRRKLRELQLRNCLRILMGELSNHHDHHDEFCLMP
Function
May be a signaling adapter molecule involved in NGFR/p75NTR-mediated apoptosis induced by NGF. Plays a role in zinc-triggered neuronal death. In absence of reductive stress, acts as a pseudosubstrate for the CRL2(FEM1B) complex: associates with FEM1B via zinc, thereby preventing association between FEM1B and its substrates.
Tissue Specificity Found in ovarian granulosa cells, testis, prostate and seminal vesicle tissue. High levels also detected in liver.
KEGG Pathway
Neurotrophin sig.ling pathway (hsa04722 )
Reactome Pathway
NADE modulates death signalling (R-HSA-205025 )

Molecular Interaction Atlas (MIA) of This DOT

7 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Thyroid gland papillary carcinoma DIS48YMM Definitive Biomarker [1]
Advanced cancer DISAT1Z9 Strong Altered Expression [2]
Glaucoma/ocular hypertension DISLBXBY Strong Biomarker [3]
Neoplasm DISZKGEW Strong Biomarker [4]
Tuberous sclerosis DISEMUGZ moderate Biomarker [5]
Nasopharyngeal carcinoma DISAOTQ0 Limited Altered Expression [2]
Neuroblastoma DISVZBI4 Limited Biomarker [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Protein BEX3 (BEX3). [6]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Protein BEX3 (BEX3). [14]
------------------------------------------------------------------------------------
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Protein BEX3 (BEX3). [7]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Protein BEX3 (BEX3). [8]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Protein BEX3 (BEX3). [9]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Protein BEX3 (BEX3). [10]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Protein BEX3 (BEX3). [11]
Phenobarbital DMXZOCG Approved Phenobarbital affects the expression of Protein BEX3 (BEX3). [12]
Menthol DMG2KW7 Approved Menthol increases the expression of Protein BEX3 (BEX3). [13]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Protein BEX3 (BEX3). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)

References

1 Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.Endocrine. 2019 Dec;66(3):573-584. doi: 10.1007/s12020-019-02021-9. Epub 2019 Jul 22.
2 BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.Cancer Med. 2017 Feb;6(2):439-451. doi: 10.1002/cam4.982. Epub 2017 Jan 13.
3 Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?.Exp Eye Res. 2009 Dec;89(6):921-33. doi: 10.1016/j.exer.2009.08.003. Epub 2009 Aug 14.
4 Induction of Bex genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells.Sci Rep. 2017 Feb 1;7:41420. doi: 10.1038/srep41420.
5 The TSC1 gene product hamartin interacts with NADE.Mol Cell Neurosci. 2007 May;35(1):100-8. doi: 10.1016/j.mcn.2007.02.007. Epub 2007 Feb 12.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
8 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
9 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
10 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
11 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
12 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
13 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
14 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
15 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.